Nicholas A. Smith

Array ( [id] => 8146881 [patent_doc_number] => 08163882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Polypeptide variants with altered effector function' [patent_app_type] => utility [patent_app_number] => 12/590801 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 37 [patent_no_of_words] => 48888 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163882.pdf [firstpage_image] =>[orig_patent_app_number] => 12590801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6593994 [patent_doc_number] => 20100048486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Use of Soluble Fgl2 As An Immunosuppressant' [patent_app_type] => utility [patent_app_number] => 12/611496 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16806 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048486.pdf [firstpage_image] =>[orig_patent_app_number] => 12611496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6502449 [patent_doc_number] => 20100260668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Dual Variable Domain Immunoglobulins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/605094 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 157517 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260668.pdf [firstpage_image] =>[orig_patent_app_number] => 12605094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497560 [patent_doc_number] => 20100093979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Fc Polypeptides With Novel Fc Ligand Binding Sites' [patent_app_type] => utility [patent_app_number] => 12/578360 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 34940 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093979.pdf [firstpage_image] =>[orig_patent_app_number] => 12578360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6449899 [patent_doc_number] => 20100145026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Antibody for ADCC And Inducing Cytokine Production' [patent_app_type] => utility [patent_app_number] => 12/576202 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4233 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20100145026.pdf [firstpage_image] =>[orig_patent_app_number] => 12576202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6608070 [patent_doc_number] => 20100323368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Cytokine production-inducing antibody' [patent_app_type] => utility [patent_app_number] => 12/585900 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5355 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323368.pdf [firstpage_image] =>[orig_patent_app_number] => 12585900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352731 [patent_doc_number] => 20100086486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES' [patent_app_type] => utility [patent_app_number] => 12/564255 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24191 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086486.pdf [firstpage_image] =>[orig_patent_app_number] => 12564255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356580 [patent_doc_number] => 20100086996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES' [patent_app_type] => utility [patent_app_number] => 12/564283 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24190 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086996.pdf [firstpage_image] =>[orig_patent_app_number] => 12564283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320606 [patent_doc_number] => 20100196388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'TARGETED BINDING AGENTS DIRECTED TO SONIC HEDGEHOG HOMOLOG AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/562435 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 54984 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196388.pdf [firstpage_image] =>[orig_patent_app_number] => 12562435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6549463 [patent_doc_number] => 20100016555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'N-Acetylglucosaminyltransferase III Expression in Lower Eukaryotes' [patent_app_type] => utility [patent_app_number] => 12/540915 [patent_app_country] => US [patent_app_date] => 2009-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 76 [patent_no_of_words] => 48653 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016555.pdf [firstpage_image] =>[orig_patent_app_number] => 12540915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166877 [patent_doc_number] => 08592555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Immunoglobulin-binding proteins with improved specificity' [patent_app_type] => utility [patent_app_number] => 12/462484 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11358 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12462484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9245536 [patent_doc_number] => 08609817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Anti-hepcidin-25 selective antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/055201 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17800 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6368063 [patent_doc_number] => 20100074900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'PROSTAGLANDIN E2 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/499652 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 110242 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074900.pdf [firstpage_image] =>[orig_patent_app_number] => 12499652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9323743 [patent_doc_number] => 08658766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'Soluble hybrid Fcγ receptors and related methods' [patent_app_type] => utility [patent_app_number] => 12/999564 [patent_app_country] => US [patent_app_date] => 2009-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 32 [patent_no_of_words] => 48045 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12999564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599825 [patent_doc_number] => 20100322849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'ENHANCED B CELL CYTOTOXICITY OF CDIM BINDING ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/490296 [patent_app_country] => US [patent_app_date] => 2009-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21457 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322849.pdf [firstpage_image] =>[orig_patent_app_number] => 12490296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599825 [patent_doc_number] => 20100322849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'ENHANCED B CELL CYTOTOXICITY OF CDIM BINDING ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/490296 [patent_app_country] => US [patent_app_date] => 2009-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21457 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322849.pdf [firstpage_image] =>[orig_patent_app_number] => 12490296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7523195 [patent_doc_number] => 08026351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => 'Monocyte-derived nucleic acids and related compositions and methods' [patent_app_type] => utility [patent_app_number] => 12/481979 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9141 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026351.pdf [firstpage_image] =>[orig_patent_app_number] => 12481979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367134 [patent_doc_number] => 20090304693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Dual Variable Domain Immunoglobulins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/477668 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 90943 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304693.pdf [firstpage_image] =>[orig_patent_app_number] => 12477668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8375471 [patent_doc_number] => 08258266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'IP-10 antibodies and their uses' [patent_app_type] => utility [patent_app_number] => 12/472877 [patent_app_country] => US [patent_app_date] => 2009-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 38759 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12472877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112152 [patent_doc_number] => 07713712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Antibodies active against a fusion polypeptide comprising a histidine portion' [patent_app_type] => utility [patent_app_number] => 12/465855 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1949 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713712.pdf [firstpage_image] =>[orig_patent_app_number] => 12465855 [rel_patent_id] =>[rel_patent_doc_number] =>)